Tahara et al demonstrated that the two-year survival rates, among one hundred twenty-six gastric carcinoma patients, clearly indicated that well-differentiated adenocarcinomas with α1-AT have worse prognosis than well-differentiated adenocarcinomas without α1-AT [20]. Here, SERPINA1 is linked to adenocarcinoma.